Glenmede Trust’s Meredith Corporation MDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-880
Closed -$11K 2500
2020
Q3
$11K Buy
880
+101
+13% +$1.41K ﹤0.01% 1865
2020
Q2
$11K Buy
779
+464
+147% +$6.76K ﹤0.01% 1843
2020
Q1
$9K Hold
315
﹤0.01% 2487
2019
Q4
$9K Buy
315
+273
+650% +$9.71K ﹤0.01% 2487
2019
Q3
$1K Hold
42
﹤0.01% 2966
2019
Q2
$2K Hold
42
﹤0.01% 2899
2019
Q1
$2K Sell
42
-5
-11% -$278 ﹤0.01% 2876
2018
Q4
$2K Buy
+47
New +$2.55K ﹤0.01% 2817
2016
Q4
Sell
-20
Closed -$1K 2669
2016
Q3
$1K Sell
20
-13
-39% -$694 ﹤0.01% 2521
2016
Q2
$1K Buy
+33
New +$1.63K ﹤0.01% 2497
2015
Q3
Sell
-31,720
Closed -$1.65M 2871
2015
Q2
$1.65M Buy
+31,720
New +$1.68M 0.01% 646
2013
Q3
Sell
-1,000
Closed -$47K 2284
2013
Q2
$47K Buy
+1,000
New +$41.1K ﹤0.01% 1537

Other funds holding MDP

Glenmede Trust's MDP Position: Q4 2020 in Review

Glenmede Trust sold out of Meredith Corporation (MDP) in Q4 2020, closing a stake of 880 shares — an estimated $11K sold.

Glenmede Trust first reported a position in MDP in Q2 2013 and held it in 12 quarters. The position peaked at $1.65M in Q2 2015. 187 funds tracked by Wall St. Rank hold MDP as of Q4 2020.

  • Glenmede Trust reported no remaining Meredith Corporation position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 880 Meredith Corporation shares in Q4 2020, an estimated $11K.
  • Glenmede Trust first reported a position in Meredith Corporation in Q2 2013 and held it in 12 quarters.
  • Glenmede Trust's Meredith Corporation position peaked at $1.65M in Q2 2015.
  • 187 funds tracked by Wall St. Rank held Meredith Corporation as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.